Goldman Sachs’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-80,701
| Closed | -$1.69M | – | 4710 |
|
|
2016
Q3 | $1.69M | Buy |
80,701
+21,751
| +37% | +$455K | ﹤0.01% | 2796 |
|
|
2016
Q2 | $636K | Buy |
58,950
+9,506
| +19% | +$103K | ﹤0.01% | 3188 |
|
|
2016
Q1 | $328K | Buy |
+49,444
| New | +$328K | ﹤0.01% | 3487 |
|
|
2015
Q4 | – | Sell |
-26,881
| Closed | -$296K | – | 4747 |
|
|
2015
Q3 | $296K | Buy |
+26,881
| New | +$296K | ﹤0.01% | 3608 |
|
|
2015
Q2 | – | Sell |
-162,261
| Closed | -$1.9M | – | 4841 |
|
|
2015
Q1 | $1.9M | Buy |
162,261
+130,700
| +414% | +$1.53M | ﹤0.01% | 2569 |
|
|
2014
Q4 | $525K | Buy |
+31,561
| New | +$525K | ﹤0.01% | 3338 |
|